Bioelectronics Corp (BIEL)

[2Relax]

That a great point I’ve never really thought about JGD. I’m so caught up in all the good news I’ve never really thought about it.

In the past only 100,000 people per year have tried Actipatch, but now that we’re starting to expand, reaching 100,000’s per quarter and soon millions per quarter, those newbies trying this for the first time have to wonder if it’s too late to invest in this new technology. When they do and find the price is still an embryo, I see lots of new investors moving in.

We know the product works really well, and the new people seeking pain relief should have their “WOW experience” using Actipatch.

Exponential growth is already in motion.